This medication belongs to the category of monoclonal antibodies. It is used in multiple treatment like non-small cell lung cancer, small cell lung cancer and melanoma. When Tecentriq 1200mg Injection in NSCLC is infused as IV containing active component atezolizumab it reactivates T-cells recognizing cancer cells making the body responsive against it. To get more info regarding this medication, you can check out Globans Pharma webpage.
Leave feedback about this
You must be logged in to post a review.